Podimetrics, an organization that helps sufferers with diabetes to forestall critical issues, is teaming up with HealthMed, an worker well being and wellness platform.
HealthMed goals to combine Podimetrics’ SmartMat expertise into its portfolio of advantages meant for big employers, hospitals and municipalities. The corporate additionally supplies worker wellness and psychological well being applications.
Podimetrics’ SmartMat measures the foot temperature of high-risk sufferers and scans for early indicators of irritation that would result in wounds, amputations and diabetic foot ulcers.
“Our partnership with HealthMed is a robust collaboration, and we’re excited to work collectively to assist people with advanced diabetes who’re on the best threat for critical issues,” Dr. Jon Bloom, CEO of Podimetrics, stated in an announcement.
“We share a typical mission to deal with prevention and enhance well being outcomes. This collaboration is geared toward attaining that objective collectively.”
Tracy Webster, founding father of HealthMed, stated the partnership with Podimetrics and its progressive answer for managing difficult diabetes will profit self-insured employers and enhance the continuum of care.
“We sit up for the constructive affect we are able to make on well being outcomes and the general value of care,” Webster stated in an announcement.
THE LARGER TREND
In March, Podimetrics partnered with profit administration group Alivi Well being, which integrated SmartMat expertise into its portfolio of specialty advantages to bolster its podiatry advantages for well being plans and payers.
In 2024, Podimetrics sued Eire-based Bluedrop Medical for patent infringement. Bluedrop has a tool that permits an individual with diabetes to scan their toes for potential cases of foot ulcers.
Based on the compliant, Bluedrop allegedly “straight and/or by subsidiaries, staff, intermediaries or commerce names” dedicated acts of infringement by “importing, providing to promote and promoting an instrumentality that infringes [Podimetrics] Patents-in-Go well with.” The case was dismissed after Podmetrics withdrew its declare.
In 2022, Podimetrics scored $45 million in a Sequence C financing spherical. The capital was used to increase Podimetrics’ product growth and analysis groups in addition to enhance the variety of companies supplied by their nurse assist groups.
In 2019, Podimmetrics raised $13.4 million in Sequence B funding. Rock Well being, Norwich Ventures and Scientific Well being Improvement every participated within the spherical.
Different firms within the diabetes house embody Dexcom, which in 2024 made a $75 million strategic funding in health-tracking ring maker Oura and established a strategic partnership to allow two-way knowledge movement between Dexcom’s steady glucose monitor (CGM) and the Oura Ring. Dexcom’s $75 million funding introduced Oura’s valuation to greater than $5 billion.
Diabetes and insulin administration software program firm Glytec and pharmaceutical agency Roche joined forces final yr to permit using Glytec’s software program in reference to Roche’s point-of-care smart-device hospital blood glucose system cobas pulse within the U.S. and world markets.
Based on Roche, cobas pulse’s strip structure supplies lab-like outcomes and lowers the necessity to repeat assessments. The system can be utilized on all affected person populations, together with neonates and intensive care sufferers.
Source link
